Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome Academic Article uri icon

Overview

MeSH Major

  • Insulin
  • Insulin-Secreting Cells
  • Osteocalcin

abstract

  • Our data demonstrate that the NMD implant achieves steady administration of GC-1, offering an effective and tightly controlled molecular delivery system for treatment of obesity and metabolic disease, thereby addressing compliance.

publication date

  • November 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/ijo.2016.129

PubMed ID

  • 27460601

Additional Document Info

start page

  • 1776

end page

  • 1783

volume

  • 40

number

  • 11